HomeBTAI • NASDAQ
add
BioXcel Therapeutics Inc
Previous close
$2.25
Day range
$2.02 - $2.20
Year range
$1.17 - $9.26
Market cap
45.05M USD
Avg Volume
724.55K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 98.00K | -54.21% |
Operating expense | 14.12M | 10.46% |
Net income | -30.91M | -126.45% |
Net profit margin | -31.54K | -394.50% |
Earnings per share | -2.18 | 57.42% |
EBITDA | -13.96M | -2.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 36.18M | -10.43% |
Total assets | 44.79M | -8.39% |
Total liabilities | 133.71M | -0.61% |
Total equity | -88.92M | — |
Shares outstanding | 21.87M | — |
Price to book | -0.51 | — |
Return on assets | -99.42% | — |
Return on capital | -324.25% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -30.91M | -126.45% |
Cash from operations | -18.79M | -14.99% |
Cash from investing | — | — |
Cash from financing | 37.53M | 8,166.96% |
Net change in cash | 18.74M | 218.01% |
Free cash flow | -11.91M | -17.45% |
About
Founded
2017
Headquarters
Website
Employees
37
